Clinical trial

Atazanavir for HIV Infected Individuals: An Early Access Program

NCT00046345

StatusNO_LONGER_AVAILABLE

Study typeEXPANDED_ACCESS

Start date2002-05-01

PhaseN/A

Study timeline

Study start (unknown)2002-05-01Date precision: month

Registry last updated2011-04-14

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

HIV Infectionsunresolved

Interventions

Atazanavir (BMS-232632)DRUG

Sponsors & collaborators

Bristol-Myers Squibblead sponsor

Mapped research locations

ChicagoIllinois, United States2 MadisonWisconsin, United States2 New YorkNew York, United States1 HoustonTexas, United States1 BostonMassachusetts, United States1 Los AngelesCalifornia, United States1 PhiladelphiaPennsylvania, United States1 DallasTexas, United States1 BaltimoreMaryland, United States1 St LouisMissouri, United States1 AtlantaGeorgia, United States1 MiamiFlorida, United States1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT00046345 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.